The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...

The new shares in the company would be allocated to investors on July 7 and would start trading on the Spanish stock market on July 9. Cirsa seeks a valuation of 2.52 billion euros ($2.97 billion) in ...

Figma, the platform that specializes in collaborative interface design, has filed for an initial public offering (IPO). The ...

AIRO Group Holdings, Inc. (“AIRO”), a company specializing in advanced aerospace and defense technologies, today announced the pricing of its initial public ...

SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual between-visit healthcare provider, today announced the pricing of its initial public offering of 7,900,000 shares of its common stock, at ...

Deals: BioNTech agreed to acquire CureVac for about $1.25 billion in an all-stock deal. RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic ...

Odyssey Therapeutics is unlikely to join the 2025 class of biotechs hitting the stock exchanges after the company withdrew its registration statement for an initial public offering (IPO). The ...

Strategy announces that it plans to conduct an initial public offering of 2,500,000 STRD shares and cash dividends at an annual rate of 10 percent. Today, Strategy (Nasdaq: MSTR; STRK; STRF) has ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. AIRO - Albuquerque, N.M., 5 ...

“2024 was a year of exceptional execution and acceleration at Metsera,” said Whit Bernard, Chief Executive Officer of Metsera.“We advanced MET-097i, our monthly, fully-biased GLP-1 RA ...

MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs beginning mid-2025 Multiple data readouts in mid and ...